The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma

This study aimed to assess the benefit of postoperative adjuvant chemotherapy in stage II–III colorectal signet ring cell carcinoma (SRCC). Qualified postoperative patients were extracted from Surveillance, Epidemiology, and End Results (SEER) database from 2004 until 2015. We collected 1675 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhuang, Yan, Na, Pan, Shu, Wang, Dun-wei, Li, Zhi-wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445263/
https://www.ncbi.nlm.nih.gov/pubmed/32839528
http://dx.doi.org/10.1038/s41598-020-70985-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445263/
https://www.ncbi.nlm.nih.gov/pubmed/32839528
http://dx.doi.org/10.1038/s41598-020-70985-0

Ejemplares similares